Odyssey Therapeutics (ODTX) IPO Deck
Odyssey Therapeutics, a clinical‑stage biopharma specializing in precision medicines for autoimmune and inflammatory disorders, unveiled its initial public offering deck in May 2026. The company aims to raise capital to advance its Phase 2‑tested pipeline, which targets conditions such as rheumatoid arthritis and lupus. By tapping public markets, Odyssey seeks to accelerate R&D and position itself amid a rapidly expanding $150 bn global market for inflammatory disease therapies. The IPO marks a pivotal step toward scaling commercial operations and broader market penetration.
Mobia Medical (MOBI) IPO Deck
Mobia Medical, a commercial‑stage medical‑device firm, is preparing an initial public offering to fund the next phase of its growth. The company’s flagship technology targets recovery for patients suffering chronic ischemic stroke, a condition affecting millions worldwide. Its device, already...
GMR Solutions (GMRS) IPO Deck
GMR Solutions, a nationwide provider of emergency medical services and out‑of‑hospital care, has released its initial public offering deck ahead of a planned listing. The deck outlines the company’s extensive ambulance fleet, mobile‑critical care units, and partnerships with hospitals and...
Fervo Energy (FRVO) IPO Deck
Fervo Energy, a developer of enhanced geothermal systems (EGS), released its IPO deck in early May 2026. The company positions its technology as a low‑carbon, baseload power solution that can be deployed in regions lacking conventional geothermal resources. The deck...
EagleRock Land (EROK) IPO Deck
EagleRock Land (ticker ERok) unveiled an IPO deck on May 5, 2026, signaling its intent to list on a U.S. exchange. The company specializes in acquiring, holding, and managing land assets in the Permian Basin, the nation’s most productive oil and gas...
Cerebras Systems (CBRS) IPO Deck
Cerebras Systems, the maker of wafer‑scale AI processors and cloud‑based AI compute services, released its initial public offering deck in early May 2026. The presentation highlights the company’s flagship Wafer‑Scale Engine, which can deliver up to 2.5 exaFLOPs of AI...
Rare Earths Americas (REA) IPO Deck
Rare Earths Americas (REA) released an IPO deck outlining its plan to go public and raise roughly $150 million. The exploration-stage firm focuses on high‑grade heavy rare earth projects in the United States, notably near the historic Mountain Pass deposit, and...
Hemab Therapeutics (COAG) IPO Deck
Hemab Therapeutics, a clinical‑stage biotechnology firm, announced its IPO deck on April 30, 2026. The company focuses on innovative therapies for rare blood‑coagulation disorders, including both bleeding and thrombotic conditions. Its pipeline features two Phase 2 candidates targeting hemophilia and antiphospholipid syndrome, and...
Suja Life (SUJA) IPO Deck
Suja Life, the cold‑pressed juice and functional‑drink brand, has released its IPO deck ahead of a planned public offering. The filing highlights rapid revenue growth, a target of $500 million in sales by 2028, and a strategy to broaden national distribution...
Seaport Therapeutics (SPTX) IPO Deck
Seaport Therapeutics, a clinical‑stage biotech firm, is preparing an initial public offering to fund its oral drug program targeting major neuropsychiatric conditions such as depression and anxiety. The company’s IPO deck emphasizes a “proven path” in neuroscience, highlighting pre‑clinical data...
HawkEye 360 (HAWK) IPO Deck
HawkEye 360, a provider of space‑based radio‑frequency signals intelligence, released its IPO deck on April 30, 2026 ahead of a planned public offering. The presentation outlines a target valuation of roughly $1.5 billion and a raise of about $200 million to expand its satellite constellation...
Avalyn Pharma (AVLN) IPO Deck
Avalyn Pharma, a clinical‑stage biopharmaceutical firm, unveiled its IPO deck on April 24, 2026, highlighting a pipeline of inhaled therapies for rare, high‑unmet‑need respiratory diseases. The company seeks to list on a U.S. exchange, positioning itself to raise capital for advancing Phase 2...
Madison Air Must Have Inhaled
Madison Air (ticker MAIR) is an HVAC roll‑up that leans heavily on hype, branding its fan installations as a revolutionary "Return on Air" solution. Management claims a 15% boost in warehouse productivity and a 30% cut in energy costs after...
The Elmet Group (ELMT) IPO Deck
Elmet Group, an industrial‑technology firm that builds critical‑materials components and high‑power microwave systems, unveiled its IPO deck on April 16, 2026. The company is seeking roughly $500 million in new capital to expand manufacturing capacity and deepen its role in the U.S. critical‑components...
Aevex: Small Drones at Scale
Aevex (AVEX) is preparing a 16‑million‑share offering priced between $18 and $22 per share. The company posted Q1 2026 revenue of $200‑$208 million, a four‑fold year‑over‑year increase, and adjusted EBITDA of $33.5‑$36.4 million, reversing a prior‑year loss. Valuation multiples now sit near 2.6×...